Danse-thérapie et Parkinson

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Substances of abuse and movement disorders: complex interactions and comorbidities

Identifieur interne : 000139 ( Pmc/Curation ); précédent : 000138; suivant : 000140

Substances of abuse and movement disorders: complex interactions and comorbidities

Auteurs : Andres Deik ; Rachel Saunders-Pullman ; Marta San Luciano

Source :

RBID : PMC:3966544

Abstract

The relationship between movement disorders and substance abuse which we previously reviewed are updated. We examine these relationships bidirectionally with focus on drugs of abuse which cause movement disorders, as well as primary movement disorders that are associated with use and abuse of alcohol and dopaminergic medications. First, we review the movement disorders that may develop from the acute use or withdrawal of frequent drugs of abuse, including alcohol, cocaine, heroin, amphetamine and methcathinone. We then comment on the interaction between alcoholism and alcohol-responsive movement disorders, such as essential tremor and myoclonus-dystonia. Lastly, we discuss the potential for abuse of antiparkinsonian dopaminergic agents in patients with Parkinson’s disease (PD).


Url:
PubMed: 23030352
PubMed Central: 3966544

Links toward previous steps (curation, corpus...)


Links to Exploration step

PMC:3966544

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Substances of abuse and movement disorders: complex interactions and comorbidities</title>
<author>
<name sortKey="Deik, Andres" sort="Deik, Andres" uniqKey="Deik A" first="Andres" last="Deik">Andres Deik</name>
</author>
<author>
<name sortKey="Saunders Pullman, Rachel" sort="Saunders Pullman, Rachel" uniqKey="Saunders Pullman R" first="Rachel" last="Saunders-Pullman">Rachel Saunders-Pullman</name>
</author>
<author>
<name sortKey="Luciano, Marta San" sort="Luciano, Marta San" uniqKey="Luciano M" first="Marta San" last="Luciano">Marta San Luciano</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PMC</idno>
<idno type="pmid">23030352</idno>
<idno type="pmc">3966544</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3966544</idno>
<idno type="RBID">PMC:3966544</idno>
<date when="2012">2012</date>
<idno type="wicri:Area/Pmc/Corpus">000251</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000251</idno>
<idno type="wicri:Area/Pmc/Curation">000139</idno>
<idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000139</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a" type="main">Substances of abuse and movement disorders: complex interactions and comorbidities</title>
<author>
<name sortKey="Deik, Andres" sort="Deik, Andres" uniqKey="Deik A" first="Andres" last="Deik">Andres Deik</name>
</author>
<author>
<name sortKey="Saunders Pullman, Rachel" sort="Saunders Pullman, Rachel" uniqKey="Saunders Pullman R" first="Rachel" last="Saunders-Pullman">Rachel Saunders-Pullman</name>
</author>
<author>
<name sortKey="Luciano, Marta San" sort="Luciano, Marta San" uniqKey="Luciano M" first="Marta San" last="Luciano">Marta San Luciano</name>
</author>
</analytic>
<series>
<title level="j">Current drug abuse reviews</title>
<idno type="ISSN">1874-4737</idno>
<idno type="eISSN">1874-4745</idno>
<imprint>
<date when="2012">2012</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass></textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">
<p id="P1">The relationship between movement disorders and substance abuse which we previously reviewed are updated. We examine these relationships bidirectionally with focus on drugs of abuse which cause movement disorders, as well as primary movement disorders that are associated with use and abuse of alcohol and dopaminergic medications. First, we review the movement disorders that may develop from the acute use or withdrawal of frequent drugs of abuse, including alcohol, cocaine, heroin, amphetamine and methcathinone. We then comment on the interaction between alcoholism and alcohol-responsive movement disorders, such as essential tremor and myoclonus-dystonia. Lastly, we discuss the potential for abuse of antiparkinsonian dopaminergic agents in patients with Parkinson’s disease (PD).</p>
</div>
</front>
</TEI>
<pmc article-type="research-article">
<pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<pmc-dir>properties manuscript</pmc-dir>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-journal-id">101468123</journal-id>
<journal-id journal-id-type="pubmed-jr-id">34540</journal-id>
<journal-id journal-id-type="nlm-ta">Curr Drug Abuse Rev</journal-id>
<journal-id journal-id-type="iso-abbrev">Curr Drug Abuse Rev</journal-id>
<journal-title-group>
<journal-title>Current drug abuse reviews</journal-title>
</journal-title-group>
<issn pub-type="ppub">1874-4737</issn>
<issn pub-type="epub">1874-4745</issn>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">23030352</article-id>
<article-id pub-id-type="pmc">3966544</article-id>
<article-id pub-id-type="manuscript">NIHMS564030</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Article</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Substances of abuse and movement disorders: complex interactions and comorbidities</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Deik</surname>
<given-names>Andres</given-names>
</name>
<degrees>MD</degrees>
<aff id="A1">Beth Israel Medical Center</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Saunders-Pullman</surname>
<given-names>Rachel</given-names>
</name>
<degrees>MD, MPH</degrees>
<aff id="A2">Beth Israel Medical Center, Albert Einstein College of Medicine</aff>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Luciano</surname>
<given-names>Marta San</given-names>
</name>
<degrees>MD, MS</degrees>
<aff id="A3">University of California, San Francisco</aff>
</contrib>
</contrib-group>
<author-notes>
<corresp id="FN1">Corresponding author: Marta San Luciano, MD, University of California San Francisco, Department of Neurology, Surgical Movement Disorders Division, 1635 Divisadero St Suite 520-530 Box 1838, San Francisco, CA 94115, Tel. (415) 353 2311, Fax (415) 353 9060,
<email>SanLucianoPalenzuelaM@neurology.ucsf.edu</email>
</corresp>
</author-notes>
<pub-date pub-type="nihms-submitted">
<day>18</day>
<month>3</month>
<year>2014</year>
</pub-date>
<pub-date pub-type="ppub">
<month>9</month>
<year>2012</year>
</pub-date>
<pub-date pub-type="pmc-release">
<day>26</day>
<month>3</month>
<year>2014</year>
</pub-date>
<volume>5</volume>
<issue>3</issue>
<fpage>243</fpage>
<lpage>253</lpage>
<abstract>
<p id="P1">The relationship between movement disorders and substance abuse which we previously reviewed are updated. We examine these relationships bidirectionally with focus on drugs of abuse which cause movement disorders, as well as primary movement disorders that are associated with use and abuse of alcohol and dopaminergic medications. First, we review the movement disorders that may develop from the acute use or withdrawal of frequent drugs of abuse, including alcohol, cocaine, heroin, amphetamine and methcathinone. We then comment on the interaction between alcoholism and alcohol-responsive movement disorders, such as essential tremor and myoclonus-dystonia. Lastly, we discuss the potential for abuse of antiparkinsonian dopaminergic agents in patients with Parkinson’s disease (PD).</p>
</abstract>
<kwd-group>
<kwd>Movement disorders</kwd>
<kwd>Parkinsonism</kwd>
<kwd>dystonia</kwd>
<kwd>chorea</kwd>
<kwd>drugs</kwd>
<kwd>tremor</kwd>
<kwd>tics</kwd>
<kwd>alcohol</kwd>
</kwd-group>
<kwd-group>
<title>ADDITIONAL KEY WORDS</title>
<kwd>Cocaine</kwd>
<kwd>amphetamines</kwd>
<kwd>Methcathinone</kwd>
<kwd>opioids</kwd>
<kwd>Heroin</kwd>
<kwd>cannabinoids</kwd>
<kwd>Marijuana</kwd>
<kwd>dopamine dysregulation syndrome</kwd>
<kwd>essential tremor</kwd>
<kwd>myoclonus-dystonia</kwd>
</kwd-group>
</article-meta>
</front>
</pmc>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Psychologie/explor/DanceTherParkinsonV1/Data/Pmc/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000139 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd -nk 000139 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Psychologie
   |area=    DanceTherParkinsonV1
   |flux=    Pmc
   |étape=   Curation
   |type=    RBID
   |clé=     PMC:3966544
   |texte=   Substances of abuse and movement disorders: complex interactions and comorbidities
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Curation/RBID.i   -Sk "pubmed:23030352" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Curation/biblio.hfd   \
       | NlmPubMed2Wicri -a DanceTherParkinsonV1 

Wicri

This area was generated with Dilib version V0.6.35.
Data generation: Sun Aug 9 17:42:30 2020. Site generation: Mon Feb 12 22:53:51 2024